2-bromo-4-trifluoromethoxyacetanilide | 886008-57-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-bromo-4-trifluoromethoxyacetanilide
• 英文别名: 2-bromo-N-[4-(trifluoromethoxy)phenyl]acetamide
• CAS: 886008-57-7
• 化学式: C₉H₇BrF₃NO₂
• 分子量: 298.059
• InChiKey: FZLRNSUSTRSHFT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-bromo-4-trifluoromethoxyacetanilide 在 nickel(II) triflate 、 C₃₈H₅₈N₄O₄ 、 sodium hydride 作用下， 以 四氢呋喃 为溶剂， 反应 2.25h， 生成
  参考文献：
  名称：

  α-重氮吡唑酰胺与硫化物的不对称催化[2,3] Stevens和Sommelet-Hauser重排。

  摘要：

  α-重氮吡唑酰胺与硫化物的催化对映选择性[2,3] Stevens和Sommelet-Hauser重排是通过使用手性N，N'-二氧化物/镍（II）络合物催化剂实现的。这些重排反应在温和的反应条件下进行得很好，可以快速，轻松地获得一系列具有高到极好的对映选择性的官能化的1,6-二羰基或亚砜取代的苯乙酸酯。催化系统显示出出色的立体控制，可区分硫的异位孤对，并控制1,3-质子转移和[2,3]-σ重排。

  DOI：

  10.1002/anie.201907164
• 作为产物：
  描述：

  溴乙酰氯 、 对三氟甲氧基苯胺 在 4-二甲氨基吡啶 作用下， 以 二氯甲烷 为溶剂， 反应 3.0h， 生成 2-bromo-4-trifluoromethoxyacetanilide
  参考文献：
  名称：

  Structure–activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH

  摘要：

  Cryptosporidium parasites are important waterborne pathogens of both humans and animals. The Cryptosporidium parvum and Cryptosporidium hominis genomes indicate that the only route to guanine nucleotides is via inosine 5 '-monophosphate dehydrogenase (IMPDH). Thus the inhibition of the parasite IMPDH presents a potential strategy for treating Cryptosporidium infections. A selective benzimidazole-based inhibitor of C. parvum IMPDH (CpIMPDH) was previously identified in a high throughput screen. Here we report a structure-activity relationship study of benzimidazole-based compounds that resulted in potent and selective inhibitors of CpIMPDH. Several compounds display potent antiparasitic activity in vitro. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.01.029

文献信息

• Substituted Pyridazin-3(2<i>H</i>)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists
  作者：Girdhar Singh Deora、Cheng Xue Qin、Elizabeth A. Vecchio、Aaron J. Debono、Daniel L. Priebbenow、Ryan M. Brady、Julia Beveridge、Silvia C. Teguh、Minh Deo、Lauren T. May、Guy Krippner、Rebecca H. Ritchie、Jonathan B. Baell

  DOI：10.1021/acs.jmedchem.8b01912

  日期：2019.5.23

  Herein we describe the development of a focused series of functionalized pyridazin-3(2 H)-one-based formyl peptide receptor (FPR) agonists that demonstrate high potency and biased agonism. The compounds described demonstrated biased activation of prosurvival signaling, ERK1/2 phosphorylation, through diminution of the detrimental FPR1/2-mediated intracellular calcium (Cai2+) mobilization. Compound

  在这里，我们描述了重点功能化的哒嗪-3（2 H）-一基甲酰肽受体（FPR）激动剂系列的开发，这些激动剂显示出高效力和偏向激动性。所描述的化合物通过减少有害的FPR1 / 2介导的细胞内钙（Cai2 +）动员，证明了生存信号的活化偏向激活，ERK1 / 2磷酸化。对于ERK1 / 2的磷酸化，化合物50的EC50为0.083μM，在hFPR1处距Cai2 +动员约20倍。
• Synthesis and Evaluation of a Class of Compounds Inhibiting the Growth of Stromal Antigen 2 ( <i>STAG2</i> )‐Mutant Ewing Sarcoma Cells
  作者：Nenggang Zhang、Keng‐Fu Lin、Christian Yang、Scott Peruski、Debananda Pati、Scott R. Gilbertson

  DOI：10.1002/cmdc.202100653

  日期：2022.5.4

  Going STAG: Selectively inhibiting cancer cells that lack stromal antigen 2 (STAG2) is an attractive approach for cancer therapy, particularly Ewing sarcoma. Herein we report a small-molecule, StagX1, and the synthesis of derivatives of such by a new route. These compounds selectively inhibit cancer cells that lack STAG2.

  走向 STAG：选择性抑制缺乏基质抗原 2 (STAG2) 的癌细胞是一种有吸引力的癌症治疗方法，尤其是尤文肉瘤。在这里，我们报告了一种小分子 StagX1，以及通过新途径合成此类衍生物的方法。这些化合物选择性地抑制缺乏 STAG2 的癌细胞。
• Design, synthesis and biological evaluation of (Quinazoline 4-yloxy)acetamide and (4-oxoquinazoline-3(4H)-yl)acetamide derivatives as inhibitors of Mycobacterium tuberculosis bd oxidase
  作者：Amit Kumar、Neetu Kumari、Sandeep Bhattacherjee、Umamageswaran Venugopal、Shahid Parwez、Mohammad Imran Siddiqi、Manju Y. Krishnan、Gautam Panda

  DOI：10.1016/j.ejmech.2022.114639

  日期：2022.11

  affinity cytochrome bd oxidase. Inhibiting the bc1 complex alone has been found bacteriostatic and not bactericidal. On the other hand, inhibition of both these oxidases turns lethal to the pathogen. In the present study, we used a bc1 complex mutant of M. tuberculosis to screen (Quinazoline 4-yloxy)acetamide and (4-oxoquinazoline-3(4H)-yl)acetamide derivatives against the alternate oxidase, i.e., cytochrome

  治疗耐药结核病迫切需要具有新作用机制的新型化学支架。结核分枝杆菌的氧化磷酸化途径由多个临床验证的药物靶点组成。该途径可以通过两种末端氧化酶中的任何一种发挥作用——质子泵细胞色素bc 1 -aa 3超复合物，或能量效率较低但亲和力高的细胞色素bd氧化酶。已发现单独抑制bc 1复合物是抑菌的而不是杀菌的。另一方面，对这两种氧化酶的抑制对病原体都是致命的。在本研究中，我们使用了bc 1结核分枝杆菌的复杂突变体筛选 (Quinazoline 4-yloxy) 乙酰胺和 (4-oxoquinazoline-3(4 H )-yl) 乙酰胺衍生物对抗交替氧化酶，即细胞色素bd氧化酶。发现两种分子 S-021-0601 和 S-021-0607 抑制突变体的 MIC 分别为 8 和 16 μM，而对野生型结核分枝杆菌的 MIC 分别为 128 和 256 μM 。在野生型中，其中一种化合物与bc 1抑制剂
• Structure–activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH
  作者：Sivapriya Kirubakaran、Suresh Kumar Gorla、Lisa Sharling、Minjia Zhang、Xiaoping Liu、Soumya S. Ray、Iain S. MacPherson、Boris Striepen、Lizbeth Hedstrom、Gregory D. Cuny

  DOI：10.1016/j.bmcl.2012.01.029

  日期：2012.3

  Cryptosporidium parasites are important waterborne pathogens of both humans and animals. The Cryptosporidium parvum and Cryptosporidium hominis genomes indicate that the only route to guanine nucleotides is via inosine 5 '-monophosphate dehydrogenase (IMPDH). Thus the inhibition of the parasite IMPDH presents a potential strategy for treating Cryptosporidium infections. A selective benzimidazole-based inhibitor of C. parvum IMPDH (CpIMPDH) was previously identified in a high throughput screen. Here we report a structure-activity relationship study of benzimidazole-based compounds that resulted in potent and selective inhibitors of CpIMPDH. Several compounds display potent antiparasitic activity in vitro. (C) 2012 Elsevier Ltd. All rights reserved.
• Asymmetric Catalytic [2,3] Stevens and Sommelet–Hauser Rearrangements of α‐Diazo Pyrazoleamides with Sulfides
  作者：Xiaobin Lin、Wei Yang、Wenkun Yang、Xiaohua Liu、Xiaoming Feng

  DOI：10.1002/anie.201907164

  日期：2019.9.16

  Catalytic enantioselective [2,3] Stevens and Sommelet-Hauser rearrangements of α-diazo pyrazoleamides with sulfides were achieved by utilizing chiral N,N'-dioxide/nickel(II ) complex catalysts. These rearrangements proceeded well under mild reaction conditions, providing rapid and facile access to a series of functionalized 1,6-dicarbonyls or sulfane-substituted phenylacetates with high to excellent

  α-重氮吡唑酰胺与硫化物的催化对映选择性[2,3] Stevens和Sommelet-Hauser重排是通过使用手性N，N'-二氧化物/镍（II）络合物催化剂实现的。这些重排反应在温和的反应条件下进行得很好，可以快速，轻松地获得一系列具有高到极好的对映选择性的官能化的1,6-二羰基或亚砜取代的苯乙酸酯。催化系统显示出出色的立体控制，可区分硫的异位孤对，并控制1,3-质子转移和[2,3]-σ重排。